Skip to main content
Clinical Trials/KCT0008656
KCT0008656
Completed
未知

Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: a pilot randomized sham-controlled trial

Kyung Hee University0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Certain infectious and parasitic diseases
Sponsor
Kyung Hee University
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 31, 2024
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Those who have been diagnosed with COVID\-19 and quarantined (and cured) at least one month ago
  • 2\) Adults between 20 and 65 years of age
  • 3\) Those who are experiencing fatigue that has persisted for more than 4 weeks after being cured of COVID\-19, and whose symptom intensity of 4 or higher on the 0\-10 numeric rating scale
  • 4\) Those who voluntarilly agree to participate in the study through a written consent form after being clearly explained of the purpose and characteristics of this clinical study

Exclusion Criteria

  • 1\) Those who have a history of diseases(cancer, anemia, hypothyroidism or psychiatric disease such as depression) or surgical operation that can cause sequelae before the infection of COVID\-19
  • 2\) Those who have a fear of acupuncture treatment
  • 3\) Women who are pregnant, may become pregnant or are lactating
  • 4\) Those who are judged that it is difficult to comply with this treatment protocol, visiting the hospital, or filing in a questionnaire, etc.
  • 5\) Those who are participating in another clinical study
  • 6\) Subjects who are judged to be inappropriate for the clinical study by the researchers

Outcomes

Primary Outcomes

Not specified

Similar Trials